Table 2 Comparison of treatment regimens between groups
From: APACHE-II score for anti-tuberculosis tolerance in critically ill patients: a retrospective study
Treatment characteristic | Drug withdrawal group (n = 147) | Therapy completion group (n = 173) | P |
|---|---|---|---|
Isoniazid (H) and rifampicin (R) | 0.27 | ||
 Neither H nor R used | 6 (4.1%) | 15 (8.7%) |  |
 H used but R not used | 48 (32.7%) | 54 (31.2%) | |
 Both H and R used | 90 (61.2%) | 104 (60.1%) | |
Use of HRZE regimen | 0.84 | ||
 HRZE regimen used | 90 (61.2%) | 104 (60.1%) |  |
 Non-HRZE regimen used | 57 (38.8%) | 69 (39.9%) | |
Number of drugs used | 0.21 | ||
  ≤ 2 | 8 (5.4%) | 17 (9.8%) |  |
 3 | 41 (27.9%) | 49 (28.3%) | |
 4 | 57 (38.8%) | 73 (42.2%) | |
 5–6 | 41 (27.9%) | 34 (19.7%) | |